Kinesiotaping Along with Mulligan's Mobilization with Movement in Adhesive Capsulitis

Effectiveness of Kinesiotaping Along with Mulligan's Mobilization with Movement on Improving Pain and Function in Patients with Adhesive Capsulitis of Shoulder: a Randomized Controlled Trial

The study aimed to evaluate the effectiveness of combining Kinesiotaping with Mulligan's mobilization with movement in treating shoulder adhesive capsulitis. Thirty patients participated in a randomized control trial, divided equally into an experimental group and a control group. The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy, while the control group received only Mulligan's mobilization with movement and conventional physiotherapy. Pain, range of motion, and functional outcomes were measured using a visual analogue scale, goniometer, and the Shoulder Pain and Disability Index (SPADI) questionnaire.

Study Overview

• Status: Completed
• Conditions: Adhesive Capsulitis
• Intervention / Treatment: Other: Kinesio taping; Other: Mulligan's mobilization with movement techniques; Other: Conventional physiotherapy

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• India
  • Kerala
    • Calicut, Kerala, India
      • Awh special college

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Primary adhesive capsulitis,
• Controlled diabetes mellitus,
• Restriction of movements in capsular pattern,
• Shoulder pain for more than one month.

Exclusion Criteria:

• Secondary adhesive capsulitis,
• Cancer,
• Bilateral adhesive capsulitis,
• Skin infections in the shoulder region,
• Shoulder joint infections,
• Wounds or ulcers in the shoulder region,
• Hypersensitivity to tape,
• Recent shoulder dislocation,
• Recent shoulder fractures.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experimental Group; The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy.	Other: Kinesio taping; Kinesio taping is a therapeutic technique that involves applying a special elastic tape to the skin to support and stabilize muscles and joints without restricting their range of motion.; Other: Mulligan's mobilization with movement techniques; Mulligan's mobilization with movement (MWM) techniques involve the application of a sustained manual force or glide to a joint while the patient actively performs a movement that is typically painful or restricted.; Other: Conventional physiotherapy; Mulligan Mobilization with Movement, Ultrasound Therapy, Active assisted ROM exercises for shoulder, Capsular Stretching exercises
Active Comparator: Control Group; Control group received only Mulligan's mobilization with movement and conventional physiotherapy	Other: Mulligan's mobilization with movement techniques; Mulligan's mobilization with movement (MWM) techniques involve the application of a sustained manual force or glide to a joint while the patient actively performs a movement that is typically painful or restricted.; Other: Conventional physiotherapy; Mulligan Mobilization with Movement, Ultrasound Therapy, Active assisted ROM exercises for shoulder, Capsular Stretching exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Visual Analogue Scale	The Visual Analog Scale (VAS) is a tool for measuring subjective experiences, like pain. It's typically a 10 cm line, with endpoints marking the extremes (e.g., "no pain" to "worst imaginable pain"). The minimum value is 0, and the maximum is 10. Respondents mark a point on the line that corresponds to their experience. Higher scores usually indicate worse outcomes for negative experiences like pain.	From enrollment to the end of treatment at 4 weeks
Range of motion	Range of motion (ROM) measures the movement extent of a joint or body part, expressed in degrees. Minimum values indicate restricted movement (e.g., 0° signifies no movement), while maximum values represent full movement capacity (e.g., 180° for shoulder flexion). Higher scores generally indicate a better outcome, as they reflect greater flexibility and joint function.	From enrollment to the end of treatment at 4 weeks
Shoulder Pain and Disability Index	The Shoulder Pain and Disability Index (SPADI) is a 13-item questionnaire assessing pain and disability due to shoulder issues. Scores range from 0 to 100, with 0 indicating no pain/disability and 100 indicating severe pain/disability. Higher scores signify worse outcomes, reflecting greater pain and functional impairment.	From enrollment to the end of treatment at 4 weeks

Collaborators and Investigators

• Sponsor: King Saud University
• Investigators: Principal Investigator: Masood Khan, MPTh, King Saud university

Study record dates

Study Major Dates

• Study Start (Actual): January 5, 2022
• Primary Completion (Actual): May 17, 2022
• Study Completion (Actual): August 11, 2022

Study Registration Dates

• First Submitted: February 15, 2025
• First Submitted That Met QC Criteria: February 19, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 19, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Keywords: Rehabilitation; Shoulder Pain; Exercise Therapy; Manual Therapy
• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Joint Diseases; Bursitis
• Other Study ID Numbers: AWH/EC/03/2021/3

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No